| NIH Convenes Panel to Assess Evidence
on Chronic Insomnia
The National Institutes of Health (NIH) will hold a
State-of-the-Science Conference on the Manifestations
and Management of Chronic Insomnia in Adults on June
13-15, 2005, at the Natcher Conference Center, on the
NIH campus in Bethesda, Maryland. A press briefing will be
held at the close of the conference, at 2:00 p.m. on
Wednesday, June 15.
During the first day and part of the second day of
the conference, experts will present the latest findings
in the research of chronic insomnia to an independent
panel. The panel will then meet in executive session
to weigh the available scientific evidence and prepare
its statement assessing the state of the science, to
be presented for public comment at 9:00 a.m. on Wednesday,
Insomnia is the most common sleep complaint reported
by women and men across all stages of adulthood and
for many, the problem is chronic. While insomnia often
exists simultaneously with other medical conditions
(co-morbidities), the definitive etiology (cause) of
insomnia remains unknown. Nevertheless, chronic insomnia
is associated with a wide range of adverse consequences
(morbidities), including depression, alcohol and drug
abuse, difficulties with concentration and memory, and
various cardiovascular, pulmonary, and gastrointestinal
disorders. In addition to reduced quality of life and
increased health care use reported by insomnia sufferers,
the large number of people experiencing insomnia ultimately
results in significant economic burden to society in
lost productivity and health care costs. Although a
number of promising behavioral and pharmacological approaches
have recently been identified for the management of
chronic insomnia symptoms, there has been limited guidance
for clinicians in terms of choice of treatment.
The panelís statement will address these five key questions:
- How is chronic insomnia defined, diagnosed, and
classified, and what is known about its etiology?
- What are the prevalence, natural history, incidence,
and risk factors for chronic insomnia?
- What are the consequences, morbidities, co-morbidities,
and public health burden associated with chronic insomnia?
- What treatments are used for the management of chronic
insomnia and what is the evidence regarding their
safety, efficacy and effectiveness?
- What are important future directions for insomnia-related
The press briefing will be held in the main auditorium
of the Natcher Center at 2:00 p.m. on Wednesday, June
15. Reporters are welcome to attend the full conference,
or just the press briefing. Please register at http://consensus.nih.gov/.
Complete conference information, including the agenda,
additional background, and logistical information, is
available at http://consensus.nih.gov/.
All open conference sessions including the press briefing
will be webcast at http://videocast.nih.gov/.
For more information, call 1-888-644-2667 or e-mail
your questions to email@example.com.
The primary sponsors of this conference are the National
Institute of Mental Health (NIMH) and the Office of
Medical Applications of Research (OMAR), both components
of the NIH.
Note to Radio Editors: An audio report of the conference
results will be available after 4:00 p.m. Wednesday,
June 15 from the NIH Radio News Service by calling 1-800-MED-DIAL
(1-800-633-3425) or visiting http://www.radiospace.com/nihhome.htm.
Note to TV Editors: The press briefing at 2:00 p.m.
on Wednesday, June 15 will be broadcast live via satellite
on the following coordinates:
C-Band Galaxy 3 Transponder 4
Orbital Location: 95 degrees west
Downlink Frequency: 3780V
Test time: 1:30 - 2:00 p.m. EDT
Broadcast: 2:00 - 3:00 p.m. EDT
The NIH comprises the Office of the Director and
27 Institutes and Centers. The Office of the Director
is the central office at NIH and is responsible for
setting policy for NIH and for planning, managing,
and coordinating the programs and activities of all
the NIH components. The NIH, the Nationís medical
research agency, is a component of the U.S. Department
of Health and Human Services.